17beta-Estradiol metabolites affect some regulators of the MCF-7 cell cycle. 1996

M L Lottering, and M de Kock, and T C Viljoen, and C J Grobler, and J C Seegers
Department of Physiology, Faculty of Medicine, University of Pretoria, South Africa.

The activity of p34(cdc2) plays a key role in the regulation of the eukaryotic cell cycle. Another cell cycle associated molecule is PCNA. We investigated the effects of 2-hydroxy-17beta-estradiol, a cell proliferator, and 2-methoxy-17beta-estradiol, a potent inhibitor of cell growth, on the levels and activity of p34(cdc2) and on the levels of PCNA, as well as on protein phosphorylation in MCF-7 cells. 2-Hydroxyestradiol increased p34(cdc2) activity at G1/S and elevated PCNA levels during S-phase. 2-Methoxyestradiol caused unscheduled activation of p34(cdc2) in S-phase and decreased levels of p34(cdc2) and PCNA during G2/M. We conclude that 2-hydroxy- and 2-methoxyestradiol have definite, though different regulatory functions during the cell cycle.

UI MeSH Term Description Entries
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D004958 Estradiol The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. 17 beta-Estradiol,Estradiol-17 beta,Oestradiol,17 beta-Oestradiol,Aerodiol,Delestrogen,Estrace,Estraderm TTS,Estradiol Anhydrous,Estradiol Hemihydrate,Estradiol Hemihydrate, (17 alpha)-Isomer,Estradiol Monohydrate,Estradiol Valerate,Estradiol Valeriante,Estradiol, (+-)-Isomer,Estradiol, (-)-Isomer,Estradiol, (16 alpha,17 alpha)-Isomer,Estradiol, (16 alpha,17 beta)-Isomer,Estradiol, (17-alpha)-Isomer,Estradiol, (8 alpha,17 beta)-(+-)-Isomer,Estradiol, (8 alpha,17 beta)-Isomer,Estradiol, (9 beta,17 alpha)-Isomer,Estradiol, (9 beta,17 beta)-Isomer,Estradiol, Monosodium Salt,Estradiol, Sodium Salt,Estradiol-17 alpha,Estradiol-17beta,Ovocyclin,Progynon-Depot,Progynova,Vivelle,17 beta Estradiol,17 beta Oestradiol,Estradiol 17 alpha,Estradiol 17 beta,Estradiol 17beta,Progynon Depot
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D016196 S Phase Phase of the CELL CYCLE following G1 and preceding G2 when the entire DNA content of the nucleus is replicated. It is achieved by bidirectional replication at multiple sites along each chromosome. S Period,Period, S,Periods, S,Phase, S,Phases, S,S Periods,S Phases
D016203 CDC2 Protein Kinase Phosphoprotein with protein kinase activity that functions in the G2/M phase transition of the CELL CYCLE. It is the catalytic subunit of the MATURATION-PROMOTING FACTOR and complexes with both CYCLIN A and CYCLIN B in mammalian cells. The maximal activity of cyclin-dependent kinase 1 is achieved when it is fully dephosphorylated. Cdk1 Protein Kinase,Cyclin-Dependent Kinase 1,Histone Kinase p34(cdc2),Protein p34cdc2,p34cdc2 Protein,cdc2+ Protein,cdk1 Kinase,Cyclin Dependent Kinase 1,Protein Kinase, CDC2,Protein Kinase, Cdk1,p34cdc2, Protein
D018809 Proliferating Cell Nuclear Antigen Nuclear antigen with a role in DNA synthesis, DNA repair, and cell cycle progression. PCNA is required for the coordinated synthesis of both leading and lagging strands at the replication fork during DNA replication. PCNA expression correlates with the proliferation activity of several malignant and non-malignant cell types. Antigen, Proliferating Cell Nuclear,PCNA

Related Publications

M L Lottering, and M de Kock, and T C Viljoen, and C J Grobler, and J C Seegers
November 1992, Cancer research,
M L Lottering, and M de Kock, and T C Viljoen, and C J Grobler, and J C Seegers
November 2006, Proteomics,
M L Lottering, and M de Kock, and T C Viljoen, and C J Grobler, and J C Seegers
April 2008, Biochemical and biophysical research communications,
M L Lottering, and M de Kock, and T C Viljoen, and C J Grobler, and J C Seegers
July 2008, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas,
M L Lottering, and M de Kock, and T C Viljoen, and C J Grobler, and J C Seegers
September 1977, Journal of animal science,
M L Lottering, and M de Kock, and T C Viljoen, and C J Grobler, and J C Seegers
December 2005, Molecules and cells,
M L Lottering, and M de Kock, and T C Viljoen, and C J Grobler, and J C Seegers
September 2001, Biochemical and biophysical research communications,
M L Lottering, and M de Kock, and T C Viljoen, and C J Grobler, and J C Seegers
September 2008, Toxicology in vitro : an international journal published in association with BIBRA,
M L Lottering, and M de Kock, and T C Viljoen, and C J Grobler, and J C Seegers
December 1998, The Journal of steroid biochemistry and molecular biology,
M L Lottering, and M de Kock, and T C Viljoen, and C J Grobler, and J C Seegers
July 2000, Endocrinology,
Copied contents to your clipboard!